Inogen, Inc.

NasdaqGS:INGN Voorraadrapport

Marktkapitalisatie: US$224.4m

Inogen Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Kevin R. Smith

Algemeen directeur

US$2.4m

Totale compensatie

Percentage CEO-salaris4.4%
Dienstverband CEOless than a year
Eigendom CEOn/a
Management gemiddelde ambtstermijnless than a year
Gemiddelde ambtstermijn bestuur2.7yrs

Recente managementupdates

Recent updates

Inogen: Upside Seems Limited After Big Move Up

Sep 24

Inogen, Inc.'s (NASDAQ:INGN) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Jul 16
Inogen, Inc.'s (NASDAQ:INGN) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Inogen: Improving, But Still Struggling For Air

Jul 01

Inogen, Inc. (NASDAQ:INGN) Stock Catapults 28% Though Its Price And Business Still Lag The Industry

May 22
Inogen, Inc. (NASDAQ:INGN) Stock Catapults 28% Though Its Price And Business Still Lag The Industry

Inogen: New Management And A Major Competitor Exit Offer Some New Opportunities

Apr 13

Inogen, Inc. (NASDAQ:INGN) Just Reported, And Analysts Assigned A US$6.50 Price Target

Mar 01
Inogen, Inc. (NASDAQ:INGN) Just Reported, And Analysts Assigned A US$6.50 Price Target

Inogen, Inc. (NASDAQ:INGN) Held Back By Insufficient Growth Even After Shares Climb 25%

Feb 01
Inogen, Inc. (NASDAQ:INGN) Held Back By Insufficient Growth Even After Shares Climb 25%

Is Inogen (NASDAQ:INGN) In A Good Position To Deliver On Growth Plans?

Oct 06
Is Inogen (NASDAQ:INGN) In A Good Position To Deliver On Growth Plans?

Inogen (NASDAQ:INGN) Is In A Strong Position To Grow Its Business

Jun 21
Inogen (NASDAQ:INGN) Is In A Strong Position To Grow Its Business

Is Inogen, Inc. (NASDAQ:INGN) Worth US$13.3 Based On Its Intrinsic Value?

Mar 14
Is Inogen, Inc. (NASDAQ:INGN) Worth US$13.3 Based On Its Intrinsic Value?

Companies Like Inogen (NASDAQ:INGN) Can Afford To Invest In Growth

Oct 27
Companies Like Inogen (NASDAQ:INGN) Can Afford To Invest In Growth

Inogen, Inc.'s (NASDAQ:INGN) Intrinsic Value Is Potentially 64% Above Its Share Price

Sep 20
Inogen, Inc.'s (NASDAQ:INGN) Intrinsic Value Is Potentially 64% Above Its Share Price

Inogen: Structural, Supply Chain Headwinds Remain

Sep 13

Inogen Non-GAAP EPS of -$0.02 beats by $0.31, revenue of $103.38M beats by $2.74M

Aug 04

Inogen: Seasonal FCF, Tightening Margins, Supply Chain Headwinds

Jun 14

At US$35.28, Is It Time To Put Inogen, Inc. (NASDAQ:INGN) On Your Watch List?

Apr 03
At US$35.28, Is It Time To Put Inogen, Inc. (NASDAQ:INGN) On Your Watch List?

Hammered By Supply Issues, Inogen Could Be A 2023 Comeback Story

Mar 31

Is There An Opportunity With Inogen, Inc.'s (NASDAQ:INGN) 28% Undervaluation?

Mar 09
Is There An Opportunity With Inogen, Inc.'s (NASDAQ:INGN) 28% Undervaluation?

Analyse CEO-vergoeding

Hoe is Kevin R. Smith's beloning veranderd ten opzichte van Inogen's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Sep 30 2024n/an/a

-US$53m

Jun 30 2024n/an/a

-US$92m

Mar 31 2024n/an/a

-US$97m

Dec 31 2023US$2mUS$108k

-US$102m

Compensatie versus markt: De totale vergoeding ($USD 2.45M ) Kevin R. } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 1.47M ).

Compensatie versus inkomsten: Er zijn onvoldoende gegevens om de beloning van Kevin R. te vergelijken met de prestaties van het bedrijf.

CEO

Kevin R. Smith (53 yo)

less than a year

Tenure

US$2,448,754

Compensatie

Mr. Kevin R. M. Smith serves as President, Chief Executive Officer and Director at Inogen Inc. since November 13, 2023. He served as Director at OncoSec Medical Incorporated since February 7, 2020 until Ju...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Kevin R. Smith
Presidentless than a yearUS$2.45mgeen gegevens
Michael Bourque
Executive VPless than a yeargeen gegevensgeen gegevens
Philip Corrin
Senior Vice President of Operations & Supply Chain1.8yrsgeen gegevensgeen gegevens
Kevin Smith
General Counsel & Executive VP of Business Developmentless than a yeargeen gegevensgeen gegevens
Jennifer Boyer
Executive VP & Chief Human Resources Officer2.5yrsgeen gegevensgeen gegevens
Grgoire Ramade
Executive VP & Chief Commercial Officerless than a yeargeen gegevensgeen gegevens
Krishna Jhaveri
Chief Medical Officerless than a yeargeen gegevensgeen gegevens
Paul Andreassi
Senior Vice President of Quality & Regulatory Affairsless than a yeargeen gegevensgeen gegevens
Adrien Mithalal
Senior Vice President of Research & Developmentless than a yeargeen gegevensgeen gegevens

0.8yrs

Gemiddelde duur

54yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van INGN wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 0.8 jaar), wat duidt op een nieuw team.

Bestuursleden

NaamPositieTenureCompensatieEigendom
Kevin R. Smith
Presidentless than a yearUS$2.45mgeen gegevens
Richard Casaburi
Member of Advisory Boardno datageen gegevensgeen gegevens
Jeffrey Kupperman
Member of Advisory Boardno datageen gegevensgeen gegevens
Paul Selecky
Member of Advisory Boardno datageen gegevensgeen gegevens
Mary Ladone
Independent Director2.7yrsUS$242.50k0.10%
$ 230.8k
Kevin King
Independent Director2.7yrsUS$250.00k0.10%
$ 230.8k
Neil MacIntyre
Member of Advisory Boardno datageen gegevensgeen gegevens
Elizabeth Mora
Independent Board Chairperson3.5yrsUS$315.00k0.11%
$ 252.6k
Robert Chatburn
Member of Advisory Boardno datageen gegevensgeen gegevens
Thomas West
Independent Director1.6yrsUS$266.24k0.079%
$ 177.9k
Heather Rider
Independent Director10.3yrsUS$242.50k0.16%
$ 356.8k
Glenn Boehnlein
Independent Director2.7yrsUS$250.00k0.10%
$ 230.8k

2.7yrs

Gemiddelde duur

62yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van INGN wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 2.7 jaar), wat duidt op een nieuw bestuur.